Chinese Journal of Dermatology ›› 2018, Vol. 51 ›› Issue (10): 711-714.doi: 10.3760/cma.j.issn.0412-4030.2018.10.001
WANG Gang
Received:2018-04-24
Revised:2018-05-26
Online:2018-10-15
Published:2018-10-03
Contact:
WANG Gang
E-mail:xjwgang@fmmu.edu.cn
WANG Gang. Neutrophils: a new hotspot in psoriasis research[J].Chinese Journal of Dermatology, 2018, 51(10): 711-714.
| ［1］ | Boehncke WH, Schön MP. Psoriasis［J］. Lancet, 2015,386（9997）:983⁃994. doi: 10.1016/S0140⁃6736（14）61909⁃7.<br /> |
| ［2］ | Wolberink EA, Peppelman M, van de Kerkhof PC, et al. Establishing the dynamics of neutrophil accumulation in vivo by reflectance confocal microscopy［J］. Exp Dermatol, 2014,23（3）:184⁃188. doi: 10.1111/exd.12345.<br /> |
| ［3］ | Perera GK, Di MP, Nestle FO. Psoriasis［J］. Annu Rev Pathol, 2012,7:385⁃422. doi: 10.1146/annurev⁃pathol⁃011811⁃132448.<br /> |
| ［4］ | Nicolás⁃Ávila JÁ, Adrover JM, Hidalgo A. Neutrophils in homeo⁃stasis, immunity, and cancer［J］. Immunity, 2017,46（1）:15⁃28. doi: 10.1016/j.immuni.2016.12.012.<br /> |
| ［5］ | Ogawa E, Sato Y, Minagawa A, et al. Pathogenesis of psoriasis and development of treatment［J］. J Dermatol, 2018,45（3）:264⁃272. doi: 10.1111/1346⁃8138.14139.<br /> |
| ［6］ | Uribe⁃Herranz M, Lian LH, Hooper KM, et al. IL⁃1R1 signaling facilitates Munro′s microabscess formation in psoriasiform imiquimod⁃induced skin inflammation［J］. J Invest Dermatol, 2013,133（6）:1541⁃1549. doi: 10.1038/jid.2012.512.<br /> |
| ［7］ | Steffen S, Abraham S, Herbig M, et al. Toll⁃like receptor⁃mediated upregulation of CXCL16 in psoriasis orchestrates neutrophil activation［J］. J Invest Dermatol, 2018,138（2）:344⁃354. doi: 10.1016/j.jid.2017.08.041.<br /> |
| ［8］ | Foster AM, Baliwag J, Chen CS, et al. IL⁃36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin［J］. J Immunol, 2014,192（12）:6053⁃6061. doi: 10.4049/jimmunol.1301 481.<br /> |
| ［9］ | Amulic B, Cazalet C, Hayes GL, et al. Neutrophil function: from mechanisms to disease［J］. Annu Rev Immunol, 2012,30:459⁃489. doi: 10.1146/annurev⁃immunol⁃020711⁃074942.<br /> |
| ［10］ | Minakawa S, Kaneko T, Matsuzaki Y, et al. Psoriasis area and severity index is closely related to serum C⁃reactive protein level and neutrophil to lymphocyte ratio in Japanese patients［J］. J Dermatol, 2017,44（10）:e236⁃236e237. doi: 10.1111/1346⁃8138. 13942.<br /> |
| ［11］ | Glowacka E, Lewkowicz P, Rotsztejn H, et al. IL⁃8, IL⁃12 and IL⁃10 cytokines generation by neutrophils, fibroblasts and neutrophils⁃fibroblasts interaction in psoriasis［J］. Adv Med Sci, 2010,55（2）:254⁃260. doi: 10.2478/v10039⁃010⁃0037⁃0.<br /> |
| ［12］ | Morizane S, Nomura H, Tachibana K, et al. The synergistic activities of the combination of tumour necrosis factor⁃α, interleukin⁃17A and interferon⁃γ in epidermal keratinocytes［J］.Br J Dermatol, 2018. doi: 10.1111/bjd.16443.<br /> |
| ［13］ | Henry CM, Sullivan GP, Clancy DM, et al. Neutrophil⁃derived proteases escalate inflammation through activation of IL⁃36 family cytokines［J］. Cell Rep, 2016,14（4）:708⁃722. doi: 10.1016/ j.celrep.2015.12.072.<br /> |
| ［14］ | Glennon⁃Alty L, Hackett AP, Chapman EA, et al. Neutrophils and redox stress in the pathogenesis of autoimmune disease［J］. Free Radic Biol Med, 2018,pii:S0891⁃5849（18）30159⁃X. doi: 10.1016/ j.freeradbiomed.2018.03.049.<br /> |
| ［15］ | Dilek N, Dilek AR, Taşkın Y, et al. Contribution of myelo⁃peroxidase and inducible nitric oxide synthase to pathogenesis of psoriasis［J］. Postepy Dermatol Alergol, 2016,33（6）:435⁃439. doi: 10.5114/ada.2016.63882.<br /> |
| ［16］ | Yang X, Yan H, Zhai Z, et al. Neutrophil elastase promotes proliferation of HaCaT cell line and transwell psoriasis organ culture model［J］. Int J Dermatol, 2010,49（9）:1068⁃1074. doi: 10. 1111/j.1365⁃4632.2010.04500.x.<br /> |
| ［17］ | Okubo K, Kamiya M, Urano Y, et al. Lactoferrin suppresses neutrophil extracellular traps release in inflammation［J］. EBioMedicine, 2016,10:204⁃215. doi: 10.1016/j.ebiom.2016.07. 012.<br /> |
| ［18］ | Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense［J］. Trends Immunol, 2009,30（3）:131⁃141. doi: 10.1016/j.it.2008.12.003.<br /> |
| ［19］ | Batycka⁃Baran A, Maj J, Wolf R, et al. The new insight into the role of antimicrobial proteins⁃alarmins in the immunopatho⁃genesis of psoriasis［J］. J Immunol Res, 2014,2014:628289. doi: 10.1155/2014/628289.<br /> |
| ［20］ | Zheng Y, Niyonsaba F, Ushio H, et al. Cathelicidin LL⁃37 induces the generation of reactive oxygen species and release of human alpha⁃defensins from neutrophils［J］. Br J Dermatol, 2007,157（6）: 1124⁃1131. doi: 10.1111/j.1365⁃2133.2007.08196.x.<br /> |
| ［21］ | Shao S, Cao T, Jin L, et al. Increased lipocalin⁃2 contributes to the pathogenesis of psoriasis by modulating neutrophil chemotaxis and cytokine secretion［J］. J Invest Dermatol, 2016,136（7）:1418⁃1428. doi: 10.1016/j.jid.2016.03.002.<br /> |
| ［22］ | Chiricozzi A, Romanelli P, Volpe E, et al. Scanning the immuno⁃pathogenesis of psoriasis［J］. Int J Mol Sci, 2018,19（1）:179. doi: 10.3390/ijms19010179.<br /> |
| ［23］ | Hagert C, Sareila O, Kelkka T, et al. The macrophage mannose receptor regulate mannan⁃induced psoriasis, psoriatic arthritis, and rheumatoid arthritis⁃like disease models［J］. Front Immunol, 2018,9:114. doi: 10.3389/fimmu.2018.00114.<br /> |
| ［24］ | Xu D, Matsumoto ML, McKenzie BS, et al. TPL2 kinase action and control of inflammation［J］. Pharmacol Res, 2018,129:188⁃193. doi: 10.1016/j.phrs.2017.11.031.<br /> |
| ［25］ | Kim HJ, Roh JY, Jung Y. Eosinophils accelerate pathogenesis of psoriasis by supporting inflammatory milieu that promotes neutrophil infiltration［J］. J Invest Dermatol, 2018,pii:S0022⁃202X（18）31744⁃5. doi: 10.1016/j.jid.2018.03.1509.<br /> |
| ［26］ | Bachelez H. Pustular psoriasis and related pustular skin diseases［J］. Br J Dermatol, 2018,178（3）:614⁃618. doi: 10.1111/bjd.16232.<br /> |
| ［27］ | Johnston A, Xing X, Wolterink L, et al. IL⁃1 and IL⁃36 are dominant cytokines in generalized pustular psoriasis［J］. J Allergy Clin Immunol, 2017,140（1）:109⁃120. doi: 10.1016/j.jaci.2016.08. 056.<br /> |
| ［28］ | Higashi Y, Yamakuchi M, Fukushige T, et al. High⁃fat diet exacerbates imiquimod⁃induced psoriasis⁃like dermatitis in mice［J］. Exp Dermatol, 2018,27（2）:178⁃184. doi: 10.1111/exd.13484.<br /> |
| ［29］ | Talukdar S, Oh DY, Bandyopadhyay G, et al. Neutrophils mediate insulin resistance in mice fed a high⁃fat diet through secreted elastase［J］. Nat Med, 2012,18（9）:1407⁃1412. doi: 10.1038/nm. 2885.<br /> |
| ［30］ | Higashi Y, Yamakuchi M, Fukushige T, et al. High⁃fat diet exacerbates imiquimod⁃induced psoriasis⁃like dermatitis in mice［J］. Exp Dermatol, 2018,27（2）:178⁃184. doi: 10.1111/exd.13484.<br /> |
| ［31］ | Naik HB, Natarajan B, Stansky E, et al. Severity of psoriasis associates with aortic vascular inflammation detected by FDG PET/CT and neutrophil activation in a prospective obser⁃vational study［J］. Arterioscler Thromb Vasc Biol, 2015,35（12）:2667⁃2676. doi: 10.1161/ATVBAHA.115.306460.<br /> |
| ［32］ | Papayannopoulos V. Neutrophil extracellular traps in immunity and disease［J］. Nat Rev Immunol, 2018,18（2）:134⁃147. doi: 10.1038/nri.2017.105.<br /> |
| ［33］ | Lee KH, Kronbichler A, Park DD, et al. Neutrophil extracellular traps （NETs） in autoimmune diseases: A comprehensive review［J］. Autoimmun Rev, 2017,16（11）:1160⁃1173. doi: 10.1016/j.autrev.2017.09.012.<br /> |
| ［34］ | Knight JS, Carmona⁃Rivera C, Kaplan MJ. Proteins derived from neutrophil extracellular traps may serve as self⁃antigens and mediate organ damage in autoimmune diseases［J］. Front Immunol, 2012,3:380. doi: 10.3389/fimmu.2012.00380.<br /> |
| ［35］ | Tadie JM, Bae HB, Jiang S, et al. HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll⁃like receptor 4［J］. Am J Physiol Lung Cell Mol Physiol, 2013,304（5）:L342⁃349. doi: 10.1152/ajplung.00151.2012.<br /> |
| ［36］ | Majewski P, Majchrzak⁃Gorecka M, Grygier B, et al. Inhibitors of serine proteases in regulating the production and function of neutrophil extracellular traps［J］. Front Immunol, 2016,7:261. doi: 10.3389/fimmu.2016.00261.<br /> |
| ［37］ | Zabieglo K, Majewski P, Majchrzak⁃Gorecka M, et al. The inhibitory effect of secretory leukocyte protease inhibitor （SLPI） on formation of neutrophil extracellular traps［J］. J Leukoc Biol, 2015,98（1）:99⁃106. doi:10.1189/jlb.4AB1114⁃543R.<br /> |
| ［38］ | Keijsers R, Hendriks AGM, van Erp PEJ, et al. In vivo induction of cutaneous inflammation results in the accumulation of extra⁃cellular trap⁃forming neutrophils expressing RORgammat and IL⁃17［J］. J Invest Dermatol, 2014,134（5）:1276⁃1284. doi:10.1038/jid.2013.526.<br /> |
| ［39］ | Skrzeczynska⁃Moncznik J, Wlodarczyk A, Banas M, et al. DNA structures decorated with cathepsin G/secretory leukocyte proteinase inhibitor stimulate IFNI production by plasmacytoid dendritic cells［J］. Am J Clin Exp Immunol, 2013,2（2）:186⁃194.<br /> |
| ［40］ | Skrzeczynska⁃Moncznik J, Wlodarczyk A, Zabieglo K, et al. Secretory leukocyte proteinase inhibitor⁃competent DNA deposits are potent stimulators of plasmacytoid dendritic cells: implication for psoriasis［J］. J Immunol, 2012,189（4）:1611⁃1617. doi: 10. 4049/ jimmunol.1103293.<br /> |
| ［41］ | Hu SC, Yu HS, Yen FL, et al. Neutrophil extracellular trap formation is increased in psoriasis and induces human β⁃defensin⁃2 production in epidermal keratinocytes［J］. Sci Rep, 2016,6:31119. doi: 10.1038/srep31119.<br /> |
| ［42］ | Macleod T, Doble R, McGonagle D, et al. Neutrophil elastase⁃mediated proteolysis activates the anti⁃inflammatory cytokine IL⁃36 receptor antagonist［J］. Sci Rep, 2016,6:24880. doi: 10.1038/srep24880.<br /> |
| ［43］ | Ainscough JS, Macleod T, McGonagle D, et al. Cathepsin S is the major activator of the psoriasis⁃associated proinflammatory cyto⁃kine IL⁃36γ［J］. Proc Natl Acad Sci U S A, 2017,114（13）:E2748⁃2748E2757. doi: 10.1073/pnas.1620954114.<br /> |
| ［44］ | Clancy DM, Henry CM, Sullivan GP, et al. Neutrophil extracellular traps can serve as platforms for processing and activation of IL⁃1 family cytokines［J］. FEBS J, 2017,284（11）:1712⁃1725. doi: 10.1111/febs.14075.<br /> |
| ［45］ | Tillack K, Breiden P, Martin R, et al. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses［J］. J Immunol, 2012,188（7）:3150⁃3159. doi: 10.4049/jimmunol.1103414.<br /> |
| ［46］ | Kahlenberg JM, Carmona⁃Rivera C, Smith CK, et al. Neutrophil extracellular trap⁃associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages［J］. J Immunol, 2013,190（3）:1217⁃1226. doi: 10.4049/jimmunol.1202388.<br /> |
| ［47］ | Chrysanthopoulou A, Mitroulis I, Apostolidou E, et al. Neutrophil extracellular traps promote differentiation and function of fibroblasts［J］. J Pathol, 2014,233（3）:294⁃307. doi: 10.1002/path. 4359.<br /> |
| ［48］ | Sumida H, Yanagida K, Kita Y, et al. Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod⁃induced psoriasis［J］. J Immunol, 2014,192（9）:4361⁃4369. doi: 10.4049/jimmunol.1302959.<br /> |
| ［49］ | Fujisawa T, Murase K, Okumura Y, et al. Generalized pustular psoriasis successfully treated with granulocyte and monocyte adsorption apheresis［J］. Ther Apher Dial, 2011,15（4）:374⁃378. doi: 10.1111/j.1744⁃9987.2011.00961.x.<br /> |
| ［50］ | Sakanoue M, Takeda K, Kawai K, et al. Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis, and associated arthropathy［J］. Ther Apher Dial, 2013,17（5）:477⁃483. doi: 10.1111/1744⁃9987.12113.<br /> |
| ［51］ | Kanekura T, Seishima M, Honma M, et al. Therapeutic depletion of myeloid lineage leukocytes by adsorptive apheresis for psoriatic arthritis: efficacy of a non⁃drug intervention for patients refractory to pharmacologics［J］. J Dermatol, 2017,44（12）:1353⁃1359. doi: 10.1111/1346⁃8138.13975.<br /> |
| ［52］ | JHO H, Schaekel K, Hartl D, et al. Dimethyl fumarate modulates neutrophil extracellular trap formation in a glutathione⁃ and superoxide⁃dependent manner［J］. Br J Dermatol, 2018,178（1）:207⁃214. doi: 10.1111/bjd.15839.<br /> |
| ［53］ | Mahil SK, Catapano M, Di MP, et al. An analysis of IL⁃36 signature genes and individuals with IL1RL2 knockout mutations validates IL⁃36 as a psoriasis therapeutic target［J］. Sci Transl Med, 2017,9（411）:pii:eaan2514. doi: 10.1126/scitranslmed.aan 2514.<br /> |
| ［54］ | Marto J, Ruivo E, Lucas SD, et al. Starch nanocapsules containing a novel neutrophil elastase inhibitor with improved pharmaceutical performance［J］. Eur J Pharm Biopharm, 2018,127:1⁃11. doi: 10. 1016/j.ejpb.2018.01.011.<br /> |
| ［55］ | Sullivan GP, Henry CM, Clancy DM, et al. Suppressing IL⁃36⁃driven inflammation using peptide pseudosubstrates for neutro⁃phil proteases［J］. Cell Death Dis, 2018,9（3）:378. doi: 10.1038/s41419⁃018⁃0385⁃4.<br /> |
| ［56］ | Yamanaka K, Umezawa Y, Yamagiwa A, et al. Biologic therapy improves psoriasis by decreasing the activity of monocytes and neutrophils［J］. J Dermatol, 2014,41（8）:679⁃685. doi: 10.1111/1346⁃8138.12560.<br /> |
| ［57］ | Reich K, Papp KA, Matheson RT, et al. Evidence that a neutrophil⁃keratinocyte crosstalk is an early target of IL⁃17A inhibition in psoriasis［J］. Exp Dermatol, 2015,24（7）:529⁃535. doi: 10.1111/exd.12710.<br /> |
| No related articles found! |
|
